3fu5: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
==Leukotriene A4 hydrolase in complex with (5-thiophen-2-ylthiophen-2-yl)methylamine== | ==Leukotriene A4 hydrolase in complex with (5-thiophen-2-ylthiophen-2-yl)methylamine== | ||
<StructureSection load='3fu5' size='340' side='right' caption='[[3fu5]], [[Resolution|resolution]] 2.30Å' scene=''> | <StructureSection load='3fu5' size='340' side='right' caption='[[3fu5]], [[Resolution|resolution]] 2.30Å' scene=''> | ||
| Line 7: | Line 8: | ||
<tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">LTA4H, LTA4 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr> | <tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">LTA4H, LTA4 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr> | ||
<tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Leukotriene-A(4)_hydrolase Leukotriene-A(4) hydrolase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.3.2.6 3.3.2.6] </span></td></tr> | <tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Leukotriene-A(4)_hydrolase Leukotriene-A(4) hydrolase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.3.2.6 3.3.2.6] </span></td></tr> | ||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3fu5 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3fu5 OCA], [http://pdbe.org/3fu5 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=3fu5 RCSB], [http://www.ebi.ac.uk/pdbsum/3fu5 PDBsum]</span></td></tr> | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3fu5 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3fu5 OCA], [http://pdbe.org/3fu5 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=3fu5 RCSB], [http://www.ebi.ac.uk/pdbsum/3fu5 PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=3fu5 ProSAT]</span></td></tr> | ||
</table> | </table> | ||
== Function == | == Function == | ||
| Line 30: | Line 31: | ||
</div> | </div> | ||
<div class="pdbe-citations 3fu5" style="background-color:#fffaf0;"></div> | <div class="pdbe-citations 3fu5" style="background-color:#fffaf0;"></div> | ||
== References == | == References == | ||
<references/> | <references/> | ||
| Line 39: | Line 37: | ||
[[Category: Human]] | [[Category: Human]] | ||
[[Category: Davies, D R]] | [[Category: Davies, D R]] | ||
[[Category: Alternative splicing]] | |||
[[Category: Cytoplasm]] | |||
[[Category: Fol]] | [[Category: Fol]] | ||
[[Category: Fragment crystallography]] | [[Category: Fragment crystallography]] | ||
| Line 49: | Line 49: | ||
[[Category: Metalloprotease]] | [[Category: Metalloprotease]] | ||
[[Category: Multifunctional enzyme]] | [[Category: Multifunctional enzyme]] | ||
[[Category: Polymorphism]] | |||
[[Category: Protease]] | [[Category: Protease]] | ||
[[Category: Zinc]] | |||
Revision as of 09:49, 1 November 2017
Leukotriene A4 hydrolase in complex with (5-thiophen-2-ylthiophen-2-yl)methylamineLeukotriene A4 hydrolase in complex with (5-thiophen-2-ylthiophen-2-yl)methylamine
Structural highlights
Function[LKHA4_HUMAN] Epoxide hydrolase that catalyzes the final step in the biosynthesis of the proinflammatory mediator leukotriene B4. Has also aminopeptidase activity.[1] [2] [3] [4] [5] [6] [7] Evolutionary Conservation Check, as determined by ConSurfDB. You may read the explanation of the method and the full data available from ConSurf. Publication Abstract from PubMedWe describe a novel fragment library termed fragments of life (FOL) for structure-based drug discovery. The FOL library includes natural small molecules of life, derivatives thereof, and biaryl protein architecture mimetics. The choice of fragments facilitates the interrogation of protein active sites, allosteric binding sites, and protein-protein interaction surfaces for fragment binding. We screened the FOL library against leukotriene A4 hydrolase (LTA4H) by X-ray crystallography. A diverse set of fragments including derivatives of resveratrol, nicotinamide, and indole were identified as efficient ligands for LTA4H. These fragments were elaborated in a small number of synthetic cycles into potent inhibitors of LTA4H representing multiple novel chemotypes for modulating leukotriene biosynthesis. Analysis of the fragment-bound structures also showed that the fragments comprehensively recapitulated key chemical features and binding modes of several reported LTA4H inhibitors. Discovery of Leukotriene A4 Hydrolase Inhibitors Using Metabolomics Biased Fragment Crystallography (dagger).,Davies DR, Mamat B, Magnusson OT, Christensen J, Haraldsson MH, Mishra R, Pease B, Hansen E, Singh J, Zembower D, Kim H, Kiselyov AS, Burgin AB, Gurney ME, Stewart LJ J Med Chem. 2009 Jul 20. PMID:19618939[8] From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine. References
|
| ||||||||||||||||||||||